One-Stop hepatitis c care could save thousands of lives
NCT ID NCT07560046
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a one-visit, point-of-care test and treat approach helps more people with HIV, hepatitis B, or hepatitis C complete hepatitis C treatment within 24 weeks compared to standard care. About 1,280 participants will be randomly assigned to either the simplified bundle or usual care. The goal is to see if faster, easier access to treatment improves cure rates for hepatitis C in key populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS B VIRUS (HBV) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Cash for care: a simple incentive to keep HIV patients on track
- Olive oil as a shield? trial tests whether a daily spoonful cuts heart risks in HIV
- Are clinics missing advanced HIV cases? a new study investigates
- Specialized HIV clinics: a new strategy to beat the virus?
- Can hormone therapy change liver health? a new study investigates
- A mobile x-ray van with AI could spot TB before it spreads